Answers are grounded in this paper and cite their sources.
Drug resistance is still a significant barrier to effective hepatocellular carcinoma therapy. Address the issue of doxorubicin resistance and inter-receptor crosstalk various doxorubicin formulations were investigated.
No takes yet. Share an insight, caveat, or question.
Abdel‐Megeed et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: